CAH
Price
$253.91
Change
-$0.42 (-0.17%)
Updated
Nov 3, 03:55 PM (EDT)
Capitalization
58.89B
2 days until earnings call
Intraday BUY SELL Signals
HSIC
Price
$83.08
Change
-$3.54 (-4.09%)
Updated
Nov 3, 04:02 PM (EDT)
Capitalization
9.65B
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

CAH vs HSIC

CAH vs HSIC Comparison Chart in %
View a ticker or compare two or three
VS
CAH vs. HSIC commentary
Nov 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a Buy and HSIC is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CAH with price predictions
Nov 02, 2026

Momentum Indicator for CAH turns positive, indicating new upward trend

CAH saw its Momentum Indicator move above the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In 65 of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 32 of 47 cases where CAH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.

CAH moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CAH crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 58%.

Following a +2.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where CAH advanced for three days, in 264 of 396 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

The Aroon Indicator entered an Uptrend today. In 188 of 310 cases where CAH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.

Bearish Trend Analysis

The 10-day RSI Indicator for CAH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 22 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 54%.

The Moving Average Convergence Divergence Histogram (MACD) for CAH turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 26 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.

CAH broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 18 (best 1 - 100 worst), indicating outstanding price growth. CAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-20.428) is normal, around the industry mean (12.613). CAH has a moderately high P/E Ratio (34.983) as compared to the industry average of (10.633). Projected Growth (PEG Ratio) (1.105) is also within normal values, averaging (2.016). Dividend Yield (0.008) settles around the average of (0.138) among similar stocks. P/S Ratio (0.217) is also within normal values, averaging (4.260).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for HSIC with price predictions
Nov 02, 2026

HSIC in upward trend: price rose above 50-day moving average on November 02, 2026

HSIC moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend. In 24 of 35 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 69%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 55 cases where HSIC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 56%.

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on HSIC as a result. In 53 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.

The Moving Average Convergence Divergence (MACD) for HSIC just turned positive on October 13, 2026. Looking at past instances where HSIC's MACD turned positive, the stock continued to rise in 22 of 44 cases over the following month. The odds of a continued upward trend are 50%.

Following a +2.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSIC advanced for three days, in 160 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSIC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.

HSIC broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HSIC entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. HSIC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.058) is normal, around the industry mean (12.613). P/E Ratio (25.035) is within average values for comparable stocks, (10.633). Projected Growth (PEG Ratio) (1.715) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.138) among similar stocks. P/S Ratio (0.750) is also within normal values, averaging (4.260).

The Tickeron Profit vs. Risk Rating rating for this company is 81 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSIC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

FUNDAMENTALS RATINGS
CAH vs HSIC: Fundamental Ratings
CAH
HSIC
OUTLOOK RATING
1..100
8233
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
75
Overvalued
PROFIT vs RISK RATING
1..100
381
SMR RATING
1..100
9964
PRICE GROWTH RATING
1..100
1845
P/E GROWTH RATING
1..100
2222
SEASONALITY SCORE
1..100
285

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAH's Valuation (30) in the Medical Distributors industry is somewhat better than the same rating for HSIC (75). This means that CAH’s stock grew somewhat faster than HSIC’s over the last 12 months.

CAH's Profit vs Risk Rating (3) in the Medical Distributors industry is significantly better than the same rating for HSIC (81). This means that CAH’s stock grew significantly faster than HSIC’s over the last 12 months.

HSIC's SMR Rating (64) in the Medical Distributors industry is somewhat better than the same rating for CAH (99). This means that HSIC’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Price Growth Rating (18) in the Medical Distributors industry is in the same range as HSIC (45). This means that CAH’s stock grew similarly to HSIC’s over the last 12 months.

CAH's P/E Growth Rating (22) in the Medical Distributors industry is in the same range as HSIC (22). This means that CAH’s stock grew similarly to HSIC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHHSIC
RSI
ODDS (%)
Bearish Trend 2 days ago
54%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
56%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
55%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
49%
Advances
ODDS (%)
Bullish Trend 19 days ago
67%
Bullish Trend 6 days ago
54%
Declines
ODDS (%)
Bearish Trend 7 days ago
43%
Bearish Trend 8 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
55%
COMPARISON
Comparison
Nov 03, 2026
Stock price -- (CAH: $254.33 vs. HSIC: $86.62)
Brand notoriety: CAH and HSIC are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 109% vs. HSIC: 199%
Market capitalization -- CAH: $58.89B vs. HSIC: $9.65B
CAH [@Medical Distributors] is valued at $58.89B. HSIC’s [@Medical Distributors] market capitalization is $9.65B. The market cap for tickers in the [@Medical Distributors] industry ranges from $44.8K to $116.4B. The average market capitalization across the [@Medical Distributors] industry is $22.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 4 FA rating(s) are green while HSIC’s FA Score has 1 green FA rating(s).

  • CAH’s FA Score: 4 green, 1 red.
  • HSIC’s FA Score: 1 green, 4 red.
According to our system of comparison, CAH is a better buy in the long-term than HSIC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 6 TA indicator(s) are bullish while HSIC’s TA Score has 5 bullish TA indicator(s).

  • CAH’s TA Score: 6 bullish, 4 bearish.
  • HSIC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CAH is a better buy in the short-term than HSIC.

Price Growth

CAH (@Medical Distributors) experienced а +1.11% price change this week, while HSIC (@Medical Distributors) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +3.18%. For the same industry, the average monthly price growth was -9.57%, and the average quarterly price growth was -19.68%.

Reported Earning Dates

CAH is expected to report earnings on Nov 05, 2026.

HSIC is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Medical Distributors (+3.18% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

View a ticker or compare two or three
CAH
Daily Signal:
Gain/Loss:
HSIC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with MCK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
+1.54%
MCK - CAH
66%
Loosely correlated
+0.38%
COR - CAH
58%
Loosely correlated
+2.12%
HSIC - CAH
11%
Poorly correlated
+2.05%
FOCL - CAH
5%
Poorly correlated
+3.83%
AHG - CAH
1%
Poorly correlated
+2.38%
More

HSIC and

Correlation & Price change

A.I.dvisor tells us that HSIC and COR have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and COR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
+2.05%
COR - HSIC
13%
Poorly correlated
+2.12%
MCK - HSIC
12%
Poorly correlated
+0.38%
CAH - HSIC
11%
Poorly correlated
+1.54%
ACH - HSIC
8%
Poorly correlated
+3.66%
YI - HSIC
7%
Poorly correlated
+3.19%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XSLV51.921.16
+2.29%
Invesco S&P SmallCap Low Volatility ETF (XSLV)
VNQ95.061.12
+1.19%
Vanguard Real Estate ETF (VNQ)
CHAU16.430.12
+0.74%
Direxion Daily CSI 300 China A Share Bull 2X ETF (CHAU)
ZTOP49.95-0.02
-0.04%
F/m High Yield 100 ETF (ZTOP)
SFLO39.91-0.13
-0.32%
VictoryShares Small Cap Free Cash Flow ETF (SFLO)